Ambu ASAMBBY +10.36%84 EBITDA Margin % is 17.42% as of Mar. 2026, which is 9% below its 10-year median of 19.08. GuruFocus rates AMBBY with a GF Score™ of 84/100 and a GF Value™ of $19.37 (Significantly Undervalued). Among 816 Medical Devices & Instruments companies, Ambu AS ranks better than 70.59% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ambu AS's EBITDA for the
three
months ended in Mar. 2026 was $42.4 Mil. Ambu AS's Revenue for the
three
months ended in Mar. 2026 was $243.3 Mil. Therefore, Ambu AS's EBITDA margin for the quarter that ended in Mar. 2026 was 17.42%.
Ambu AS (OTCPK:AMBBY) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ambu AS EBITDA Margin % Related Terms
Ambu AS EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ambu AS's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMBBY vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Ambu AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambu AS EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ambu AS's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambu AS (AMBBY) has a EBITDA Margin % of 17.42% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ambu AS and its competitors. This is near median its historical median of 19.08. Over the past decade, Ambu AS's EBITDA Margin % has ranged from 11.07 to 23.45. According to the industry distribution chart, Ambu AS ranks #240 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 29.4%.
Is Ambu AS's EBITDA Margin % too high?
Ambu AS's current EBITDA Margin % of 17.42% is near median its 10-year median of 19.08. Over the past 10 years, this metric has ranged from a low of 11.07 to a high of 23.45. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Ambu AS's value of 17.42% is 133% above this industry median. Based on the distribution chart, Ambu AS ranks #240 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ambu AS has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ambu AS ranks #240 out of 816 companies for EBITDA Margin %. This puts Ambu AS in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Ambu AS's value of 17.42% is 133% above this benchmark. Historically, Ambu AS's own EBITDA Margin % has ranged from 11.07 to 23.45 over the past decade. While the company's 10-year median is 19.08 vs. the industry median of 7.48, Ambu AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambu AS's current EBITDA Margin % of 17.42% is 133% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ambu AS and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambu AS's current EBITDA Margin % is 17.42%, which is near median its own 10-year median of 19.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (AMBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.37, compared to a current price of $9.43 — trading 51.3% below its estimated fair value. The current EBITDA Margin % is 17.42%, which is near median its 10-year median of 19.08 and 133% above the Medical Devices & Instruments industry median of 7.48. Ambu AS's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ambu AS (AMBBY), the current EBITDA Margin % is 17.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambu AS (AMBBY) Overvalued in 2026?
Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued.
The current stock price of $9.43 is trading 51.3% below its estimated GF Value™ of $19.37.
GuruFocus considers Ambu AS to be Significantly Undervalued.
Key valuation signals for AMBBY:
EBITDA Margin %: 17.42% (near median its 10-year median of 19.08)
GF Value™: $19.37 vs. price of $9.43 (51.3% below fair value)
Industry Position: 133% above the Medical Devices & Instruments median (#240 of 816)
No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
84GF Score
Get the complete analysis for AMBBY
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMBBY has been successfully added to your 
